Cardinal Health, Inc. (CAH) Receives Consensus Recommendation of “Hold” from Analysts
Cardinal Health, Inc. (NYSE:CAH) has received an average recommendation of “Hold” from the eighteen ratings firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $76.69.
Several equities research analysts recently commented on CAH shares. UBS AG restated a “neutral” rating and issued a $76.00 price target (down previously from $79.00) on shares of Cardinal Health in a research report on Thursday, August 3rd. Credit Suisse Group restated an “outperform” rating and issued a $87.00 price target (up previously from $81.00) on shares of Cardinal Health in a research report on Thursday, July 13th. BidaskClub downgraded shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Zacks Investment Research downgraded shares of Cardinal Health from a “hold” rating to a “sell” rating in a research report on Monday, August 7th. Finally, Cowen and Company restated a “market perform” rating and issued a $77.00 price target (down previously from $82.00) on shares of Cardinal Health in a research report on Thursday, August 3rd.
ILLEGAL ACTIVITY NOTICE: “Cardinal Health, Inc. (CAH) Receives Consensus Recommendation of “Hold” from Analysts” was published by American Banking News and is the property of of American Banking News. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/10/04/cardinal-health-inc-cah-receives-consensus-recommendation-of-hold-from-analysts.html.
Institutional investors have recently added to or reduced their stakes in the business. Brandes Investment Partners LP acquired a new position in Cardinal Health in the 2nd quarter valued at approximately $2,464,000. Sheets Smith Wealth Management increased its stake in Cardinal Health by 0.8% in the 2nd quarter. Sheets Smith Wealth Management now owns 36,800 shares of the company’s stock valued at $2,867,000 after buying an additional 300 shares during the period. Victory Capital Management Inc. increased its stake in Cardinal Health by 202.1% in the 2nd quarter. Victory Capital Management Inc. now owns 61,304 shares of the company’s stock valued at $4,776,000 after buying an additional 41,013 shares during the period. Dupont Capital Management Corp acquired a new position in Cardinal Health in the 2nd quarter valued at approximately $164,000. Finally, Swiss National Bank increased its stake in Cardinal Health by 1.6% in the 2nd quarter. Swiss National Bank now owns 1,152,648 shares of the company’s stock valued at $89,814,000 after buying an additional 18,600 shares during the period. Hedge funds and other institutional investors own 87.98% of the company’s stock.
Cardinal Health (NYSE:CAH) traded down 0.12% during mid-day trading on Wednesday, reaching $67.52. 2,333,675 shares of the company’s stock traded hands. The company has a 50-day moving average of $67.07 and a 200-day moving average of $73.63. The company has a market capitalization of $21.37 billion, a price-to-earnings ratio of 16.75 and a beta of 0.86. Cardinal Health has a 52-week low of $62.70 and a 52-week high of $84.88.
Cardinal Health (NYSE:CAH) last released its earnings results on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business had revenue of $32.97 billion during the quarter, compared to analyst estimates of $32.73 billion. During the same period in the prior year, the business earned $1.14 earnings per share. The business’s quarterly revenue was up 5.0% on a year-over-year basis. Equities research analysts expect that Cardinal Health will post $4.95 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Sunday, October 15th. Shareholders of record on Monday, October 2nd will be paid a $0.4624 dividend. The ex-dividend date is Friday, September 29th. This represents a $1.85 annualized dividend and a yield of 2.74%. Cardinal Health’s dividend payout ratio is presently 45.79%.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.